Carl Zeiss Meditec Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Markus Weber
Chief executive officer
€1.1m
Total compensation
| CEO salary percentage | 40.5% |
| CEO tenure | 2.3yrs |
| CEO ownership | n/a |
| Management average tenure | 4yrs |
| Board average tenure | 2.9yrs |
Recent management updates
Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being
May 21
How Should Investors Feel About Carl Zeiss Meditec's (ETR:AFX) CEO Remuneration?
Feb 16
Recent updates
Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?
Mar 24Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Mar 11Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement
Feb 12Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
Jan 29What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?
Dec 08Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital
Nov 08Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price
Oct 24Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?
Sep 24Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?
Sep 08Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
Jul 24We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)
Jun 19Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?
Jun 06Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?
May 22Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price
Apr 19Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet
Feb 26Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 10Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching
Jan 28Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10
Jan 12Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10
Dec 29Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10
Dec 14What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?
Nov 04Calculating The Intrinsic Value Of Carl Zeiss Meditec AG (ETR:AFX)
Oct 18Investors Will Want Carl Zeiss Meditec's (ETR:AFX) Growth In ROCE To Persist
Sep 12Carl Zeiss Meditec (ETR:AFX) Seems To Use Debt Rather Sparingly
Aug 25Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Hit The Brakes
May 30Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Feb 27Carl Zeiss Meditec's (ETR:AFX) Returns Have Hit A Wall
Feb 08Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching
Dec 12Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger
Nov 06If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late
Sep 06Investors Met With Slowing Returns on Capital At Carl Zeiss Meditec (ETR:AFX)
Aug 08Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being
May 21Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems
May 18Capital Allocation Trends At Carl Zeiss Meditec (ETR:AFX) Aren't Ideal
Apr 28Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 19% Below Its Share Price
Mar 09How Should Investors Feel About Carl Zeiss Meditec's (ETR:AFX) CEO Remuneration?
Feb 16What Type Of Shareholders Own The Most Number of Carl Zeiss Meditec AG (ETR:AFX) Shares?
Jan 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | €277m |
| Sep 30 2023 | €1m | €426k | €290m |
| Jun 30 2023 | n/a | n/a | €308m |
| Mar 31 2023 | n/a | n/a | €278m |
| Dec 31 2022 | n/a | n/a | €307m |
| Sep 30 2022 | €1m | €298k | €294m |
Compensation vs Market: Markus's total compensation ($USD1.12M) is below average for companies of similar size in the German market ($USD5.57M).
Compensation vs Earnings: Markus's compensation has been consistent with company performance over the past year.
CEO
Markus Weber
2.3yrs
Tenure
€1,050,400
Compensation
Dr. Markus Weber is CEO & Chairman of Management Board of Carl Zeiss Meditec AG from January 01, 2022 and served as its President since January 01, 2022 until December 2022. He joined ZEISS Semiconductor M...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of Management Board | 2.3yrs | €1.05m | no data | |
| CFO & Member of the Management Board | 5.5yrs | €799.30k | no data | |
| Head of Global Regulatory & Clinical Affairs | 1.3yrs | no data | no data | |
| Chief Operating Officer | no data | no data | no data | |
| Director of Investor Relations | no data | no data | no data | |
| Chief Human Resources Officer | no data | no data | no data | |
| Chief Medical Officer for Global Ophthalmic Devices | 7.5yrs | no data | no data | |
| Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec | 4.1yrs | no data | no data | |
| President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit | 3.9yrs | no data | no data | |
| Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology | no data | no data | no data |
4.0yrs
Average Tenure
58yo
Average Age
Experienced Management: AFX's management team is considered experienced (4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Head of Global Regulatory & Clinical Affairs | 1.1yrs | no data | no data | |
| Chairman of the Supervisory Board | 3.8yrs | no data | no data | |
| Honorary Chairman of the Supervisory Board | 2.9yrs | €43.10k | no data | |
| Member of the Supervisory Board | 3.8yrs | €36.00k | no data | |
| Member of the Supervisory Board | 2.9yrs | €55.00k | no data | |
| Employee Representative Member of the Supervisory Board | 1.1yrs | no data | no data | |
| Member of the Supervisory Board | 6yrs | €52.00k | no data | |
| Employee Representative Deputy Chairman of Supervisory Board | 4.5yrs | €40.50k | no data | |
| Employee Representative Member of Supervisory Board | 4.1yrs | €36.00k | no data | |
| Member of Supervisory Board | 2.9yrs | no data | no data | |
| Employee Representative Member of the Supervisory Board | 2.1yrs | €19.20k | no data | |
| Employee Representative Member of the Supervisory Board | 1.1yrs | no data | no data |
2.9yrs
Average Tenure
52yo
Average Age
Experienced Board: AFX's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.